Core Outcome Measures in Effectiveness Trials

Development of a core outcome set for gastric cancer treatment trials.

General Information

This will form the basis of an NIHR-funded doctoral research fellowship with the aims of developing a core outcome set to be used by gastric cancer treatment trials. The study will also identify definitions and appropriate outcome measurement instruments to be used by the core outcome set.

For more information visit

Mr Bilal Alkhaffaf, Central Manchester University Hospitals NHS Foundation Trust
Professor Iain Bruce, Central Manchester University Hospitals NHS Foundation Trust
Professor Paula Williamson, University of Manchester
Professor Anne-Marie Glenny, University of Manchester
Professor Jane Blazeby, University of Bristol

Further Study Information

Current Stage:
October 2015 - October 2020
Funding source(s):
NIHR Doctoral Research Fellowship

Health Area

Disease Category

Disease Name
Gastric Cancer

Target Population

Age Range
18 - 100


Nature / type of Intervention


Consensus meeting
Delphi process
Systematic review

Stage 1 – Protocol design, ethics approval and systematic review.
Stage 2 – Patient interviews and Delphi process followed by consensus meeting to finalise COS.
Stage 3 – Identify measurement instrument tools to be used in COS.

Stakeholders Involved

Clinical experts

Study Type

COS for clinical trials or clinical research
Recommended outcome measures (measurement)

The site uses cookies, some may have been set already. Please refer to our privacy policy & cookie usage statement.
If you continue to use the site we'll assume you're happy to accept the cookies.